T1	Participants 59 109	ADHD with comorbid depressive or anxiety symptoms.
T2	Participants 368 466	population of children and adolescents with ADHD and concurrent symptoms of depression or anxiety.
T3	Participants 474 557	Patients were randomized to treatment with fluoxetine (n = 127) or placebo (n = 46)
T4	Participants 1219 1294	pediatric patients with ADHD and comorbid symptoms of depression or anxiety
